Chemed Co. (NYSE:CHE) Shares Sold by NewEdge Wealth LLC

NewEdge Wealth LLC lowered its stake in shares of Chemed Co. (NYSE:CHE) by 0.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,839 shares of the company’s stock after selling 23 shares during the period. NewEdge Wealth LLC’s holdings in Chemed were worth $3,094,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Argonautica Private Wealth Management Inc. boosted its stake in shares of Chemed by 7.2% during the fourth quarter. Argonautica Private Wealth Management Inc. now owns 505 shares of the company’s stock valued at $268,000 after acquiring an additional 34 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Chemed by 3.5% during the fourth quarter. Bank of New York Mellon Corp now owns 142,255 shares of the company’s stock valued at $75,366,000 after acquiring an additional 4,838 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of Chemed during the fourth quarter valued at $835,000. Cabot Wealth Management Inc. boosted its stake in shares of Chemed by 2.0% during the fourth quarter. Cabot Wealth Management Inc. now owns 23,421 shares of the company’s stock valued at $12,408,000 after acquiring an additional 460 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its stake in shares of Chemed by 2.6% during the fourth quarter. Handelsbanken Fonder AB now owns 3,972 shares of the company’s stock valued at $2,104,000 after acquiring an additional 100 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on CHE shares. StockNews.com lowered Chemed from a “buy” rating to a “hold” rating in a research note on Thursday. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Chemed Trading Up 2.4 %

Shares of NYSE:CHE opened at $600.46 on Friday. The stock’s 50-day moving average price is $545.15 and its two-hundred day moving average price is $563.27. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The firm has a market cap of $9.04 billion, a price-to-earnings ratio of 30.34, a PEG ratio of 2.15 and a beta of 0.48.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s payout ratio is 10.11%.

Insider Transactions at Chemed

In other news, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were bought at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.